Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT03979404
Eligibility Criteria:
Inclusion Criteria:
* Male and female participants over the age of 13
* BMI over 14 (for participants over the age of 18) or over 66% of the median BMI for age and gender (for participants under the age of 18)
* Right-handed
* Current Diagnostic and Statistical Manual-5 (DSM-5) diagnosis of AN-restricting type (AN-R) or AN-binge/purge type (AN-BP) and an illness duration of 3 years or more
* Must have completed at least one adequate previous course of eating disorder treatment (e.g. one 6-month course of specialist outpatient therapy, specialist day-care or in-patient treatment for refeeding)
* Participants under the age of 18 must have informed consent from parent(s)/carer(s)
* Must have approval from treating eating disorders clinician or general practitioner (GP) to participate
Exclusion Criteria:
* Having a history of head or eye injury
* Having a history of a neurological disease including previous seizures of any kind
* Having metallic implants anywhere in the head or body
* Being on a dose of any psychotropic medication that has not been stable for at least 14 days prior to participation in the study
* Taking antipsychotic medication
* Taking anti-convulsive medication
* Pregnancy or suspected pregnancy in female participants
* Having a current other major psychiatric disorder (e.g. major depressive disorder, substance dependence, schizophrenia or bipolar) needing treatment in its own right
* Excessive alcohol (\>3 units per day, 5 days of the week) and/or cigarette consumption (\>15 cigarettes per day)
* Severe abnormalities in the screening clinical blood sample
* An rTMS safety questionnaire and an MRI safety questionnaire will also be administered and if deemed not safe to deliver rTMS or undergo MRI scanning, people will be excluded on this basis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Maximum Age:
70 Years
Study:
NCT03979404
Study Brief:
Protocol Section:
NCT03979404